Printer Friendly
The Free Library
5,671,890 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Validation master plans - Lapses in records seen as bug-a-boo in FDA inspections.


PHILADELPHIA Firms must be wary of lapses in their validation See validate.

validation - The stage in the software life-cycle at the end of the development process where software is evaluated to ensure that it complies with the requirements.
 documents, including master plans, that would wave red flags during an FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 inspection, an industry consultant reported here at a Barnett International conference held Sept. 20-21.

"For instance, the tests described in the protocol must challenge all the process or equipment parameters described in the spec," said David Dills, corporate manager of quality services and regulatory affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas:
 at Perigon, Jacksonville, FL.

Also, the FDAer will check to see if atypical atypical /atyp·i·cal/ (-i-k'l) irregular; not conformable to the type; in microbiology, applied specifically to strains of unusual type.

a·typ·i·cal
adj.
 data points are explained adequately in the validation conclusion or summary, he said. Referenced procedures should be available as an attachment or through the document control system. All deviations must be explained and qualified.

The sample size must be appropriate. "An FDA inspector would frown at the lame lame (lam) incapable of normal locomotion; deviating from normal gait.

lame
adj.
1. Disabled so that movement, especially walking, is difficult or impossible.

2.
 excuse that you failed to use a sufficiently large In mathematics, the phrase sufficiently large is used in contexts such as:
is true for sufficiently large
 sample because your lab was unable to handle it," Dills said. "That's like saying you have no SOP because no one in QA knew how to create one."

Dills warned against writing a protocol after testing, rather than before. When he asked if anyone in the audience had ever done so, there were a few titters.

Lapses in validation records raise red flags in FDA audits, but master plans not required Dills He emphasized the importance of document clarity. "I once read a 25-page SOP and was lost by the first paragraph of the second page," he said. "An FDA inspector would definitely be less patient than I was. Avoid technical jargon jargon, pejorative term applied to speech or writing that is considered meaningless, unintelligible, or ugly. In one sense the term is applied to the special language of a profession, which may be unnecessarily complicated, e.g., "medical jargon.  and make sure it can be understood by a ninth grade student without the help of an engineer."

How long should a document be? Dills said: "I once reviewed a firm's validation master plan that was only one page long. It was adequate because the firm had only seven employees and produced one product with a single piece of equipment. Another firm might need 600 pages or more. "

Dills noted that FDA and the Quality System (QS) rules do not require validation master plans. Industry adopted master planning to control costs. "Validation costs then were running up to 13% of the total cost of installed projects," Dills stated. "Today, validation makes up approximately 8% of a project's budget."
COPYRIGHT 2000 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:United States Food and Drug Administration auditing standards
Author:Dechnik, Peter
Publication:Validation Times
Article Type:Brief Article
Geographic Code:1USA
Date:Oct 1, 2000
Words:367
Previous Article:'Comparability protocols' touted as time-saving tools.(United States Food and Drug Administration on biologics industry)(Brief Article)
Next Article:Quality systems - Risk analysis seen benefitting firms in recall situations.(Fran Akelewicz, Becton-Dickinson and Co.)(Brief Article)
Topics:



Related Articles
Gull Labs buy leaves Meridian with suspended products, warning Letter.(Meridian Diagnostics)(Brief Article)
Part-time processor bails out rather than face FDA validation rules.(Brief Article)
Tampa firm slapped for GMP, NDA deviations.(Brief Article)
Catalytica nets warning letter from one-page 483.(Catalytica Phrmaceuticals Inc.)
Hi-Tech, FDA still hashing out January '99 inspection.(Brief Article)
Summer inspection puts heat on Gensia Sicor.
Leiras follow-up okays fixes, cites E-Sig issues.(Food and Drug Administration investigated apparent violation of its electronic signature rule,...
Wyeth, FDA argue over qualification, validation.(Food and Drug Administration investigated Wyeth-Ayerst)
Merger, validation slips converge at Novartis.(Brief Article)
Analysis of 483s/EIRs for GMP validation issues.(United States Food and Drug Administration on Forest Laboratories Inc. and Losochimica)(Statistical...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles